These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 18362227)
1. Aminopeptidase A: could it be a novel target for neurogenic hypertension? Ferreira AJ; Raizada MK Hypertension; 2008 May; 51(5):1273-4. PubMed ID: 18362227 [No Abstract] [Full Text] [Related]
2. Aminopeptidase A inhibitors as centrally acting antihypertensive agents. Bodineau L; Frugière A; Marc Y; Claperon C; Llorens-Cortes C Heart Fail Rev; 2008 Sep; 13(3):311-9. PubMed ID: 18175217 [TBL] [Abstract][Full Text] [Related]
3. Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension. Bodineau L; Frugière A; Marc Y; Inguimbert N; Fassot C; Balavoine F; Roques B; Llorens-Cortes C Hypertension; 2008 May; 51(5):1318-25. PubMed ID: 18362226 [TBL] [Abstract][Full Text] [Related]
4. Central antihypertensive effects of orally active aminopeptidase A inhibitors in spontaneously hypertensive rats. Marc Y; Gao J; Balavoine F; Michaud A; Roques BP; Llorens-Cortes C Hypertension; 2012 Aug; 60(2):411-8. PubMed ID: 22710644 [TBL] [Abstract][Full Text] [Related]
5. Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure. Marc Y; Boitard SE; Balavoine F; Azizi M; Llorens-Cortes C Can J Cardiol; 2020 May; 36(5):721-731. PubMed ID: 32389345 [TBL] [Abstract][Full Text] [Related]
6. Aminopeptidase A, generating one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, plays a key role in central control of blood pressure. Rozenfeld R; Reaux A; Iturrioz X; Fassot C; Fournie-Zaluski MC; David C; Maigret B; Roques BP; Corvol P; Llorens-Cortes C Proc West Pharmacol Soc; 2003; 46():39-44. PubMed ID: 14699881 [No Abstract] [Full Text] [Related]
7. A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin system with aminopeptidase A inhibitors. Gao J; Marc Y; Iturrioz X; Leroux V; Balavoine F; Llorens-Cortes C Clin Sci (Lond); 2014 Aug; 127(3):135-48. PubMed ID: 24697296 [TBL] [Abstract][Full Text] [Related]
8. NI956/QGC006, a Potent Orally Active, Brain-Penetrating Aminopeptidase A Inhibitor for Treating Hypertension. Keck M; De Almeida H; Compère D; Inguimbert N; Flahault A; Balavoine F; Roques B; Llorens-Cortes C Hypertension; 2019 Jun; 73(6):1300-1307. PubMed ID: 31067198 [TBL] [Abstract][Full Text] [Related]
9. Brain ACE2 activation following brain aminopeptidase A blockade by firibastat in salt-dependent hypertension. Hmazzou R; Marc Y; Flahault A; Gerbier R; De Mota N; Llorens-Cortes C Clin Sci (Lond); 2021 Mar; 135(6):775-791. PubMed ID: 33683322 [TBL] [Abstract][Full Text] [Related]
10. Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension. Fournie-Zaluski MC; Fassot C; Valentin B; Djordjijevic D; Reaux-Le Goazigo A; Corvol P; Roques BP; Llorens-Cortes C Proc Natl Acad Sci U S A; 2004 May; 101(20):7775-80. PubMed ID: 15136730 [TBL] [Abstract][Full Text] [Related]
11. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure. Reaux A; Iturrioz X; Vazeux G; Fournie-Zaluski MC; David C; Roques BP; Corvol P; Llorens-Cortes C Biochem Soc Trans; 2000; 28(4):435-40. PubMed ID: 10961935 [TBL] [Abstract][Full Text] [Related]
12. Central antihypertensive effects of chronic treatment with RB150: an orally active aminopeptidase A inhibitor in deoxycorticosterone acetate-salt rats. Marc Y; Hmazzou R; Balavoine F; Flahault A; Llorens-Cortes C J Hypertens; 2018 Mar; 36(3):641-650. PubMed ID: 28968260 [TBL] [Abstract][Full Text] [Related]
13. Human brain aminopeptidase A: biochemical properties and distribution in brain nuclei. de Mota N; Iturrioz X; Claperon C; Bodineau L; Fassot C; Roques BP; Palkovits M; Llorens-Cortes C J Neurochem; 2008 Jul; 106(1):416-28. PubMed ID: 18410507 [TBL] [Abstract][Full Text] [Related]
14. Role of angiotensin III in hypertension. Reaux-Le Goazigo A; Iturrioz X; Fassot C; Claperon C; Roques BP; Llorens-Cortes C Curr Hypertens Rep; 2005 Apr; 7(2):128-34. PubMed ID: 15748538 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Firibastat, A First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins. Ferdinand KC; Balavoine F; Besse B; Black HR; Desbrandes S; Dittrich HC; Nesbitt SD Circulation; 2019 Jul; 140(2):138-146. PubMed ID: 31014072 [TBL] [Abstract][Full Text] [Related]
16. The characteristics, functions and inhibitors of three aminopeptidases belonging to the m1 family. Luan Y; Ma C; Wang Y; Fang H; Xu W Curr Protein Pept Sci; 2012 Aug; 13(5):490-500. PubMed ID: 22954453 [TBL] [Abstract][Full Text] [Related]
17. The role of the brain renin-angiotensin system in hypertension: implications for new treatment. Marc Y; Llorens-Cortes C Prog Neurobiol; 2011 Oct; 95(2):89-103. PubMed ID: 21763394 [TBL] [Abstract][Full Text] [Related]
18. [Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension]. Llorens-Cortès C Biol Aujourdhui; 2014; 208(3):217-24. PubMed ID: 25474003 [TBL] [Abstract][Full Text] [Related]
19. Conversion of renal angiotensin II to angiotensin III is critical for AT2 receptor-mediated natriuresis in rats. Padia SH; Kemp BA; Howell NL; Fournie-Zaluski MC; Roques BP; Carey RM Hypertension; 2008 Feb; 51(2):460-5. PubMed ID: 18158338 [TBL] [Abstract][Full Text] [Related]
20. [Identification of metabolic pathways of brain angiotensin II and angiotensin III: predominant role of angiotensin III in the control of vasopressin secretion]. Llorens-Cortes C C R Seances Soc Biol Fil; 1998; 192(4):607-18. PubMed ID: 9842467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]